NovioGendix Research B.V.

https://www.noviogendix.com

NovioGendix, based in Nijmegen (The Netherlands), is a molecular diagnostic company providing an expert-based, integrated approach in developing advanced and clinically useful molecular diagnostic assays for uro-oncological practice. NovioGendix has a range of diagnostic tests for prostate, bladder, kidney and other urologic cancers in various stages of development. Commencing activities in 2008 as a Radboud University Medical Center (Radboudumc) spin-off company, NovioGendix has a standing cooperation with various Radboudumc departments. The main shareholders of NovioGendix include BioGeneration Ventures, and Participatiemaatschappij Oost Nederland. *

	Start	2006-01-01 established
	End	2016-01-01 renamed before
	Group	MDxHealth (Group)
	Today	MDxHealth Research B.V.
	Successor	MDxHealth Research B.V.
	Industry	molecular diagnostics
	Industry 2	diagnostic services

	Region	Nijmegen
	Country	Netherlands
	City	6524 GA Nijmegen
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2025-03-16

Picture Berlin Partner News New Research Centers BeCat S-IM 650x200px

More documents for MDxHealth (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]